Hepatitis B and primary liver cancer.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000382:microbiology* / Q000517:prevention & control; D002353:Carrier State / Q000276:immunology / Q000517:prevention & control; D002460:Cell Line; D002908:Chronic Disease; D004274:DNA, Recombinant; D004279:DNA, Viral / Q000235:genetics; D006509:Hepatitis B / Q000276:immunology / Q000382:microbiology* / Q000517:prevention & control; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology / Q000648:ultrastructure; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D008113:Liver Neoplasms / Q000382:microbiology* / Q000517:prevention & control; D008114:Liver Neoplasms, Experimental / Q000276:immunology; D051379:Mice; D008819:Mice, Nude; D014612:Vaccines / Q000592:standards; D014779:Virus Replication
D004274:DNA, Recombinant; D004279:DNA, Viral; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D014612:Vaccines